| This week's sponsor is IBM Watson Health. | | | Visually Explore Real-world Evidence…
...by disease/product, without programming, statistical, or clinical knowledge. Watch our Video
IBM Access and Value Connect: built on MarketScan® claims and Explorys® EHR databases. |
Today's Rundown Novartis' Kymriah head jumps ship to T-cell biotech Atara as its R&D chief quits Genmab files for $500M IPO to fund multi-front cancer R&D push Inovio shares fall as AstraZeneca pares down partnership Novartis powers Notch cancer biotech Ayala to $30M series B Centrexion farms out pain drug to Lilly for $47.5M and could reap much more Featured Story | | | Wednesday, May 29, 2019 Novartis has lost its head of oncology and lead for its global head, cell and gene therapy unit Pascal Touchon as he steps up to become the CEO and president of California biotech Atara Biotherapeutics. |
|
|
Top Stories Wednesday, May 29, 2019 Genmab has filed to raise up to $500 million in an IPO on the Nasdaq. The huge offering will set Genmab up to take antibody-drug conjugate tisotumab vedotin to market in cervical cancer while pushing other programs through the clinic. Wednesday, May 29, 2019 As the dust settles on a continued exodus at AstraZeneca and faces and units are replaced, it seems the U.K.-based Big Pharma is starting to look at cutting some of the fat from its external pacts, and Inovio Pharmaceuticals is in the crosshairs. Wednesday, May 29, 2019 Novartis has powered Ayala Pharmaceuticals to a $30 million series B round. Ayala will use the cash to fund mid-phase development of pan-Notch inhibitor AL101 in adenoid cystic carcinoma. Tuesday, May 28, 2019 Eli Lilly is paying $47.5 million upfront to license Centrexion Therapeutics’ phase 1 non-opioid pain drug. Centrexion stands to net up to $575 million in development and regulatory milestones as well as another $375 million if the drug makes it to market. | This week's sponsor is Medical Sensors Expo & Conference. | | | |
Resources Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. Sponsored by: Catalent Download the executive summary to learn key considerations for a successful technology transfer for manufacturing drug products, including a case study on overcoming challenges in a process transfer for a sterile diluent. Sponsored by: Patheon, part of Thermo Fisher Scientific Choosing the Best Sterile Dosage Form for Your Phase I Clinical Supply Needs. Sponsored by: Patheon, part of Thermo Fisher Scientific Designed with speed & flexibility,Quick to Clinic™ for Oral Solid Dose helps deliver products to Phase I Clinic in as little as 14 weeks. Sponsored by: AlphaSense What is agile competitive intelligence, and how can help healthcare researchers stay ahead of the curve? Sponsored by: JPEO-CBRND – Medical Countermeasure Systems MCS is currently seeking broad-based industry/academia collaboration on research and prototype work in technical areas related to developing medical countermeasures for the Joint Warfighter. Sponsored by: Outer Edge Technology Learn how the cloud can support the performance and security requirements for validated, mission-critical applications historically designed and implemented exclusively via on-premises deployment. Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. 2019 BIO International Convention June 3-6, 2019 | Philadelphia, PA FierceBiotech Executive Breakfast at BIO 2019 – Getting Real: The Changing Tide on Real-World Evidence in Drug Development June 5, 2019 | Philadelphia, PA Medical Sensors Design Conference June 25, 2019 | McEnery Convention Center | San Jose, CA Sensors Expo & Conference June 25-27, 2019 | McEnery Convention Center | San Jose, CA Drug Development Boot Camp® 2019 November 20-21, 2019 | Boston, MA | Register and start preparing Today! | 